Impact of Silver Nanoparticles on Haemolysis, Platelet Function and Coagulation

Nanobiomedicine

Volumn 1, Issue , 2014, Pages

  Laloy, Julie ^a   Minet, Valentine ^a   Alpan, Lutfiye ^a   Mullier, François ^a,b   Beken, Sonja ^c   Toussaint, Olivier ^a   Lucas, Stéphane ^a   Dogné, Jean Michel ^a  

^a University of Namur   (Belgium)

^b UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

^c Federal Agency for Medicines and Health Products Belgium   (Belgium)

Author keywords

Coagulation; Platelets; Red Blood Cells; Silver Nanoparticles

Indexed keywords

EID: 85028008434     PISSN: None     EISSN: 18495435     Source Type: Journal    
DOI: 10.5772/59346     Document Type: Article

References (46)

1. Chaloupka K, Malam Y, Seifalian AM. (2010) Nanosilver as a new generation of nanoproduct in biomedical applications. Trends Biotechnol. 28:580–8.
2. Lansdown AB. (2010) A pharmacological and toxicological profile of silver as an antimicrobial agent in medical devices. Adv Pharmacol Sci. 2010:910686.
3. Ahamed M, Alsalhi MS, Siddiqui MK. (2010) Silver nanoparticle applications and human health. Clin Chim Acta. 411:1841–8.
4. Mohanty S, Mishra S, Jena P, Jacob B, Sarkar B, Sonawane A., (2012) An investigation on the antibacterial, cytotoxic, and antibiofilm efficacy of starch-stabilized silver nanoparticles. Nanomedicine. 8:916–24.
5. Shahverdi AR, Fakhimi A, Shahverdi HR, Minaian S., (2007) Synthesis and effect of silver nanoparticles on the antibacterial activity of different antibiotics against Staphylococcus aureus and Escherichia coli. Nanomedicine. 3:168–71.
6. Scholars WWICf. A nanotechnology consumer products inventory.
7. Benn TM, Westerhoff P., (2008) Nanoparticle silver released into water from commercially available sock fabrics. Environ Sci Technol. 42:4133–9.
8. Chaudhry Q, Scotter M, Blackburn J, Ross B, Boxall A, Castle L, (2008) Applications and implications of nanotechnologies for the food sector. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 25:241–58.
9. Chen X, Schluesener HJ. (2008) Nanosilver: A nanoproduct in medical application. Toxicol Lett. 176:1–12.
10. You J, Zhang Y, Hu Z., (2011) Bacteria and bacteriophage inactivation by silver and zinc oxide nanoparticles. Colloids Surf B Biointerfaces. 85:161–7.
11. Greulich C, Diendorf J, Gessmann J, Simon T, Habijan T, Eggeler G, (2011) Cell type-specific responses of peripheral blood mononuclear cells to silver nanoparticles. Acta Biomater. 7:3505–14.
12. Dreaden EC, El-Sayed MA. (2012) Detecting and destroying cancer cells in more than one way with noble metals and different confinement properties on the nanoscale. Acc Chem Res. 45:1854–65.
13. Nadworny PL, Wang J, Tredget EE, Burrell RE. (2008) Anti-inflammatory activity of nanocrystalline silver in a porcine contact dermatitis model. Nanomedicine. 4:241–51.
14. Kwan KH, Yeung KW, Liu X, Wong KK, Shum HC, Lam YW, (2013) Silver nanoparticles alter proteoglycan expression in the promotion of tendon repair. Nanomedicine. DOI: 10.1016/j.nano.2013.11.015.
15. Sung JH, Ji JH, Yoon JU, Kim DS, Song MY, Jeong J, (2008) Lung function changes in Sprague-Dawley rats after prolonged inhalation exposure to silver nanoparticles. Inhal Toxicol. 20:567–74.
16. Oberdorster G, Oberdorster E, Oberdorster J., (2005) Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect. 113:823–39.
17. Sung JH, Ji JH, Park JD, Yoon JU, Kim DS, Jeon KS, (2009) Subchronic inhalation toxicity of silver nanoparticles. Toxicol Sci. 108:452–61.
18. Takenaka S, Karg E, Roth C, Schulz H, Ziesenis A, Heinzmann U, (2001) Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. Environ Health Perspect. 109 Suppl 4:547–51.
19. Kim YS, Song MY, Park JD, Song KS, Ryu HR, Chung YH, (2010) Subchronic oral toxicity of silver nanoparticles. Part Fibre Toxicol. 7:20.
20. Dobrovolskaia MA, Clogston JD, Neun BW, Hall JB, Patri AK, McNeil SE. (2008) Method for analysis of nanoparticle hemolytic properties in vitro. Nano Lett. 8:2180–7.
21. Smith SA. (2009) The cell-based model of coagulation. J Vet Emerg Crit Care (San Antonio). 19:3–10.
22. Laloy J, Robert S, Marbehant C, Mullier F, Mejia J, Piret JP, (2012) Validation of the calibrated thrombin generation test (cTGT) as the reference assay to evaluate the procoagulant activity of nanomaterials. Nanotoxicology. 6:213–32.
23. Mejia J, Tichelaar F, Saout C, Toussaint O, Masereel B, Mekhalif Z, (2011) Effects of the dispersion methods in Pluronic F108 on the size and the surface composition of MWCNTs and their implications in toxicology assessment. Journal of Nanopart Res. 13:655–67.
24. Laloy J, Mullier F, Alpan L, Mejia J, Lucas S, Chatelain B, (2014) A comparison of six major platelet functional tests to assess the impact of carbon nanomaterials on platelet function: A practical guide. Nanotoxicology. 8:220–32.
25. Choi J, Reipa V, Hitchins VM, Goering PL, Malinauskas RA. (2011) Physicochemical characterization and in vitro hemolysis evaluation of silver nanoparticles. Toxicol Sci. 123:133–43.
26. Jun EA, Lim KM, Kim K, Bae ON, Noh JY, Chung KH, (2011) Silver nanoparticles enhance thrombus formation through increased platelet aggregation and procoagulant activity. Nanotoxicology. 5:157–67.
27. Krajewski S, Prucek R, Panacek A, Avci-Adali M, Nolte A, Straub A, (2013) Hemocompatibility evaluation of different silver nanoparticle concentrations employing a modified Chandler-loop in vitro assay on human blood. Acta Biomater. 9:7460–8.
28. Shrivastava S, Singh SK, Mukhopadhyay A, Sinha AS, Mandal RK, Dash D., (2011) Negative regulation of fibrin polymerization and clot formation by nanoparticles of silver. Colloids Surf B Biointerfaces. 82:241–6.
29. Shrivastava Siddhartha TB, Singh Sunil K., Singh Gajendra, Ramachandrarao Dash Debabrata, (2009) Characterization of antiplatelet properties of silver nanoparticles. ACS Nano. 3:1357–64.
30. Bouwmeester H, Lynch I, Marvin HJ, Dawson KA, Berges M, Braguer D, (2011) Minimal analytical characterization of engineered nanomaterials needed for hazard assessment in biological matrices. Nanotoxicology. 5:1–11.
31. Taurozzi JS, Hackley VA, Wiesner MR. (2011) Ultrasonic dispersion of nanoparticles for environmental, health and safety assessment–issues and recommendations. Nanotoxicology. 5:711–29.
32. Shi J, Hedberg Y, Lundin M, Wallinder Odnevall I, Karlsson HL, Moller L., (2012) Hemolytic properties of synthetic nano- and porous silica particles: The effect of surface properties and the protection by the plasma corona. Acta Biomater. 8:3478–90.
33. Lundqvist M, Stigler J, Cedervall T, Berggard T, Flanagan MB, Lynch I, (2011) The evolution of the protein corona around nanoparticles: A test study. ACS Nano. 5:7503–9.
34. Kwon T, Woo HJ, Kim YH, Lee HJ, Park KH, Park S, (2012) Optimizing hemocompatibility of surfactant-coated silver nanoparticles in human erythrocytes. J Nanosci Nanotechnol. 12:6168–75.
35. de Mel A, Chaloupka K, Malam Y, Darbyshire A, Cousins B, Seifalian AM. (2012) A silver nanocomposite biomaterial for blood-contacting implants. J Biomed Mater Res A. 100:2348–57.
36. Rother RP, Bell L, Hillmen P, Gladwin MT. (2005) The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: A novel mechanism of human disease. JAMA. 293:1653–62.
37. Ballinger PM, Brown BS, Griffin MM, Steven FS. (1982) Evidence for carriage of silver by sulphadimidine: Haemolysis of human erythrocytes. Br J Pharmacol. 77:141–5.
38. Sopjani M, Foller M, Haendeler J, Gotz F, Lang F., (2009) Silver ion-induced suicidal erythrocyte death. J Appl Toxicol. 29:531–6.
39. Nohl H, Stolze K., (1998) The effects of xenobiotics on erythrocytes. Gen Pharmacol. 31:343–7.
40. Shrivastava S, Bera T, Singh SK, Singh G, Ramachandrarao P, Dash D., (2009) Characterization of antiplatelet properties of silver nanoparticles. ACS Nano. 3:1357–64.
41. Deb S, Raja SO, Dasgupta AK, Sarkar R, Chattopadhyay AP, Chaudhuri U, (2012) Surface tunability of nanoparticles in modulating platelet functions. Blood Cells Mol Dis. 48:36–44.
42. Tian J, Wong KK, Ho CM, Lok CN, Yu WY, Che CM, (2007) Topical delivery of silver nanoparticles promotes wound healing. ChemMedChem. 2:129–36.
43. Martinez-Gutierrez F, Thi EP, Silverman JM, de Oliveira CC, Svensson SL, Vanden Hoek A, (2012) Antibacterial activity, inflammatory response, coagulation and cytotoxicity effects of silver nanoparticles. Nanomedicine. 8:328–36.
44. Reinke JM, Sorg H., (2012) Wound repair and regeneration. Eur Surg Res. 49:35–43.
45. European Medicine Agency (EMA). (2008) ICH Topic M 3 (R2) Non-clinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals. CPMP/ICH/286/95. 1–22.
46. European Medicine Agency (EMA). (2014) Qualification of novel methodologies for drug development: Guidance to applicants. EMA/CHMP/SAWP/72894. 1–16.